In silico modification of Zn2+ binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds as Homo sapiens class II HDAC inhibitor of cervical cancer
Research output: Contribution to journal › Conference article › peer-review
4Citations
(Scopus)
Fingerprint
Dive into the research topics of 'In silico modification of Zn2+ binding group of suberoylanilide hydroxamic acid (SAHA) by organoselenium compounds as Homo sapiens class II HDAC inhibitor of cervical cancer'. Together they form a unique fingerprint.